PTGX
Protagonist Ther (PTGX)
NASDAQ
$151.44+$3.26 (+2.20%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $9.6B
    Market Cap
  • 151.75%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 77
Valuation
PTGX
vs History
vs S&P 500
Profitability
0
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 62
Valuation
PTGX
vs History
vs S&P 500
3-Month Momentum
43.58%
12-Month Momentum
154.71%
3-Month Risk Adjusted Momentum
238.39%
12-Month Risk Adjusted Momentum
311.03%

True Yield

N/A
Valuation
PTGX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.53%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 79
Valuation
PTGX
vs History
vs S&P 500
Ohlson's O-Score
12